
Sign up to save your podcasts
Or
In this episode we talk about the results of the CRASH-2 trial published in Lancet. This trial showed that the EARLY use of Tranexamic acid may improve survivial, but delayed use may be associated with an increased mortality.
4.8
649649 ratings
In this episode we talk about the results of the CRASH-2 trial published in Lancet. This trial showed that the EARLY use of Tranexamic acid may improve survivial, but delayed use may be associated with an increased mortality.
938 Listeners
1,071 Listeners
893 Listeners
380 Listeners
11,363 Listeners
63,248 Listeners
2,866 Listeners
3,925 Listeners
1,527 Listeners
1,861 Listeners
318 Listeners
248 Listeners
8,367 Listeners
246 Listeners
207 Listeners